ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q1SCImago #8,691Hybrid

ChemMedChem

Acronym:cmdc
•
Abbreviation (ISO):CHEMMEDCHEM
•
Identifier (ISSN):1860-7179(Print)/1860-7187(Online)
•
Publisher:John Wiley and Sons Ltd
Clarivate IF (2026)
3.5↑ +0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for ChemMedChem

WoS Q2
23453.0120183.0220193.1220203.4720213.5420223.420233.620243.420253.52026
Annual Impact Factor Metric
Current (2026):3.5
Scopus SJR & RankScopus Q1
0.67
#8,691

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
130

130 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate2.8%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
304articles/year
31.05% Gold OA•85.71% Original Research

Aims & Scope

Quality research. Outstanding publications. With an impact factor of 3.124 (2019), ChemMedChem is a top journal for research at the interface of chemistry, biology and medicine. It is published on behalf of Chemistry Europe, an association of 16 European chemical societies. ChemMedChem publishes primary as well as critical secondary and tertiary information from authors across and for the world. Its mission is to integrate the wide and flourishing field of medicinal and pharmaceutical sciences, ranging from drug design and discovery to drug development and delivery, from molecular modeling to combinatorial chemistry, from target validation to lead generation and ADMET studies. ChemMedChem typically covers topics on small molecules, therapeutic macromolecules, peptides, peptidomimetics, and aptamers, protein-drug conjugates, nucleic acid therapies, and beginning 2017, nanomedicine, particularly 1) targeted nanodelivery, 2) theranostic nanoparticles, and 3) nanodrugs. Contents ChemMedChem publishes an attractive mixture of: Full Papers and Communications Reviews and Minireviews Patent Reviews Highlights and Concepts Book and Multimedia Reviews.

Topics Covered (Recognized by AI)
Chemistry92.9%Biology84.4%Biochemistry75.9%Genetics69.4%Medicine66.2%Organic chemistry56%Stereochemistry44.1%Physics44.1%Internal medicine43.8%Nuclear magnetic resonance31.1%Pharmacology31%Combinatorial chemistry28.6%Gene26.4%In vitro25.8%Enzyme23.2%Materials science22.4%Receptor20.7%Computational biology20.1%Computer science20.1%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

CHEMISTRY, MEDICINAL

Q2
Rank36/72
IndexSCIE
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q2
Rank134/356
IndexSCIE
JCISCIE2026

CHEMISTRY, MEDICINAL

Q2
Rank33/72
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q2
Rank146/356
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3.5
Articles / Year363
Total Citations140
2025
IF3.4
Articles / Year347
Total Citations841
2024
IF3.6
Articles / Year404
Total Citations2,352
2023
IF3.4
Articles / Year253
Total Citations2,264
2022
IF3.54
Articles / Year294
Total Citations3,501

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #8,691Scopus Q1SCImago Profile
Scopus Coverage:2006-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyChemistryPharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q1
0.67

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
3.47

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,133 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,669
3-Year Documents747
Citable Documents736

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate42.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Q1
BiochemistryQ2
Drug DiscoveryQ2
Organic ChemistryQ2
PharmacologyQ2
Molecular MedicineQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 2.8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区CHEMISTRY, MEDICINAL
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

ChemMedChem (acronym: cmdc, abbr: CHEMMEDCHEM, ISSN: 1860-7179) is a peer-reviewed international scholarly journal in the field of Medicine, published by John Wiley and Sons Ltd in Germany since 2006. The periodical holds a Journal Impact Factor (JIF) of 3.50, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.670 (Q1), an H-index of 130.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 304 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,133 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
John Wiley and Sons Ltd
Publication Language
English
Frequency
Monthly
Founding Year
2006
Indexing & Databases
SCIEScopusPubMed
Editorial Address
WILEY-V C H VERLAG GMBH, PO BOX 10 11 61, WEINHEIM, GERMANY, D-69451

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 42e119dd-cc6d-4d67-b948-c6c71ff985ae
Database Updated: 2026-10-01